相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid
John E. Eaton et al.
HEPATOLOGY (2020)
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease
F. Anthony Romero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
Donatella Chianelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
How effective are nonalcoholic fatty liver disease models for drug discovery?
Jana Hundertmark et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists
Raj A. Shah et al.
EXPERT OPINION ON EMERGING DRUGS (2020)
Molecular tuning of farnesoid X receptor partial agonism
Daniel Merk et al.
NATURE COMMUNICATIONS (2019)
Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
Aline Gottlieb et al.
CELLS (2019)
Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials
Elizabeth M. Brunt et al.
HEPATOLOGY (2019)
Design and synthesis of bridged piperidine and piperazine isosteres
Gaetan Maertens et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
David C. Tully et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition
Min-Jin Kim et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Carmen G. Tag et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Knocking on FXR's Door: The Hammerhead-Structure Series of FXR Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
Christian Gege et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
The Bile Acid Receptor TGR5 Activates the TRPA1 Channel to Induce Itch in Mice
TinaMarie Lieu et al.
GASTROENTEROLOGY (2014)
The TGR5 receptor mediates bile acid-induced itch and analgesia
Farzad Alemi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064
Adwoa Akwabi-Ameyaw et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
Structural basis for bile acid binding and activation of the nuclear receptor FXR
LZ Mi et al.
MOLECULAR CELL (2003)
Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7α-hydroxylase gene repression by bile acids
KS Bramlett et al.
MOLECULAR GENETICS AND METABOLISM (2000)
分享论文
